Up Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -162.53%
- Ebitda -140.94%
- Net Worth -0.14%
- Total Assets 8.90%
About Up Biotech
Up Biotech Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 October 2009 and has a history of 15 years and four months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vivek Ladhani and Indira Devi serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01403UP2009PTC038459
- Company No.
038459
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Up Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Ladhani  | Director | 08-Jun-2016 | Current |
| Indira Devi | Director | 24-Apr-2016 | Current |
Financial Performance of Up Biotech.
Up Biotech Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 162.53% decrease in profit. The company's net worth dipped by a decrease of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Up Biotech?
In 2015, Up Biotech had a promoter holding of 99.33% and a public holding of 0.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Brindavan Bottlers Private LimitedVivek Ladhani and Indira Devi are mutual person
Slmg Beverages Private LimitedVivek Ladhani is a mutual person
Sunshine Sales Private LimitedVivek Ladhani and Indira Devi are mutual person
- Pratikar Fin-Lease Private Limited
Vivek Ladhani and Indira Devi are mutual person
- Nitya Ventures Llp
Vivek Ladhani is a mutual person
- Lks Infra Llp
Vivek Ladhani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Up Biotech?
Unlock and access historical data on people associated with Up Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Up Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Up Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
